Come up with a name for your new list and we'll add to it:
Cerevast Therapeutics raised a round of funding on April 22, 2013. Investors include
Genstar Capital Partners.
Cerevast Therapeutics is developing a non-invasive treatment for acute ischemic stroke known as sonothrombolysis, or SonoLysis for short. This treatment harnesses the acoustic energy from externally a…